For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its
For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its
Lifesaving research by scientists, doctors and others around our country is being threatened by what’s happening currently in Washington, D.C., say officials of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC). “Medical
BUCKS COUNTY – November 1, 2024 – State Senator Steve Santarsiero (D-10) announced today $7,449,800 million in state funds from the Redevelopment Assistance Capital Program (RACP) for eight projects across the 10th Senate District.The awards are as follows:$500,000 to Bristol
The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) announced today (Nov. 1) that Allen B. Reitz, PhD, Chief Executive Officer of Fox Chase Therapeutics Discovery Inc., has been chosen for the second annual
New York State officials today announced the team that has been selected to build and launch BioGenesis, a cell and gene therapy center on Long Island, which will include a biotech incubator to be managed by the
This year’s Regional Biotechnology Conference at the PABC also will feature a panel discussion with top life sciences CEOs in the region. Rick Siger, Pennsylvania Secretary of Community and Economic Development, and Jennifer Griffin, PhD, partner with
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC). When Timothy M. Block, PhD, an award-winning virologist and accomplished inventor, launched the Pennsylvania Biotechnology Center (PABC) in 2006,
Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD, the pioneer of therapeutic applications of guanylate cyclase-C (GC-C) signaling and an inventor of the widely prescribed medicine Trulance(R), has been awarded a Phase 1 SBIR grant from
Powered by the Hatch BioFund, the PABC’s 10th Annual Entrepreneur Spotlight featured the event’s first major financial incentive. A promising biotech startup from Philadelphia was chosen from among three stellar companies presenting at the 10th Annual Entrepreneur Spotlight
The Pennsylvania Biotechnology Center (PABC) has appointed Nick Spring, BSc (Hons), DipM, MCIM, a former executive in the pharmaceutical industry, as its first Entrepreneur in Residence. At the outset, Nick is advising five spinout companies from the